Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Poornima Murali to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- University of California - LAC Medical Center, Los Angeles, California, 90033
- University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California, 90033
-
Texas
- Univeristy of Texas Health Science Center in San Antonio, San Antonio, Texas, 78229
-
Illinois
- Northwestern University, Chicago, Illinois, 60611
-
Michigan
- Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan, 49503
Powered by
SC CTSI